Redhill Biopharma (RDHL) vs 60 Degrees Pharmaceuticals (SXTP)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Redhill Biopharma is the larger company by market cap ($4.2 million vs $3.9 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | RDHL | SXTP |
|---|---|---|
| Share price | $0.474 | $1.10 |
| Market cap | $4.21M | $3.87M |
| 1-day change | -2.07% | -0.90% |
| Forward P/E | 15.80 | — |
| EPS (TTM) | $0.00 | $-5.34 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.14 | $8.62 |
| 52-week low | $0.465 | $0.84 |
| Distance from 52-week high | -77.85% | -87.24% |
| Average volume | 1.84M | 129.39K |
| Shares outstanding | 8.89M | 3.52M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
RDHL vs SXTP FAQ
Which is bigger, Redhill Biopharma or 60 Degrees Pharmaceuticals?
Redhill Biopharma (RDHL) is larger, with a market capitalization of $4.21M compared with $3.87M for 60 Degrees Pharmaceuticals (SXTP).
Are Redhill Biopharma and 60 Degrees Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.